{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:04:29Z","timestamp":1781654669498,"version":"3.54.5"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s10067-020-05126-z","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T11:02:45Z","timestamp":1595329365000},"page":"3701-3705","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Performance of the 2017 EUSTAR activity index in an scleroderma cohort"],"prefix":"10.1007","volume":"39","author":[{"given":"Laura","family":"Ross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molla","family":"Huq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Strickland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Sahhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene-Siew","family":"Ngian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Roddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Proudman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandana","family":"Nikpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,21]]},"reference":[{"key":"5126_CR1","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1002\/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U","volume":"43","author":"V Steen","year":"2000","unstructured":"Steen V, Medsger TA (2000) Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 43:2437\u20132444","journal-title":"Arthritis Rheum"},{"key":"5126_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1177\/2397198318765061","volume":"3","author":"L Ross","year":"2018","unstructured":"Ross L, Baron M, Nikpour M (2018) The challenges and controversies of measuring disease activity in systemic sclerosis. J Scleroderma Relat Dis 3:115\u2013121","journal-title":"J Scleroderma Relat Dis"},{"key":"5126_CR3","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1136\/ard.60.6.592","volume":"60","author":"G Valentini","year":"2001","unstructured":"Valentini G, Della Rossa A, Bombardieri S, Bencivelli W, Silman AJ, D'Angelo S, Cerinic MM, Belch JF, Black CM, Bruhlmann P, Czirj\u00e1k L, de Luca A, Drosos AA, Ferri C, Gabrielli A, Giacomelli R, Hayem G, Inanc M, McHugh N, Nielsen H, Rosada M, Scorza R, Stork J, Sysa A, van den Hoogen F, Vlachoyiannopoulos PJ (2001) European multicentre study to define disease activity criteria for systemic sclerosis.* II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 60:592\u2013598","journal-title":"Ann Rheum Dis"},{"key":"5126_CR4","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1136\/annrheumdis-2016-209768","volume":"76","author":"G Valentini","year":"2017","unstructured":"Valentini G, Iudici M, Walker UA, Jaeger VK, Baron M, Carreira P, Czirj\u00e1k L, Denton CP, Distler O, Hachulla E, Herrick AL, Kowal-Bielecka O, Pope J, M\u00fcller-Ladner U, Riemekasten G, Avouac J, Frerix M, Jordan S, Minier T, Siegert E, Ong VH, Vettori S, Allanore Y (2017) The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index. Ann Rheum Dis 76:270\u2013276","journal-title":"Ann Rheum Dis"},{"issue":"Suppl. 29","key":"5126_CR5","first-page":"S42","volume":"21","author":"TA Medsger","year":"2003","unstructured":"Medsger TA, Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W (2003) Assessment of disease severity and prognosis. Ciln Exp Rheumatol 21(Suppl. 29):S42\u2013S46","journal-title":"Ciln Exp Rheumatol"},{"key":"5126_CR6","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson S, Baron M, Tyndall A et al (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 72:1747\u20131755","journal-title":"Ann Rheum Dis"},{"key":"5126_CR7","unstructured":"National Health and Medical Research Council of Australia (2015) National statement on ethical conduct in research involving humans"},{"key":"5126_CR8","first-page":"1892","volume":"20","author":"P Clements","year":"1993","unstructured":"Clements P, Lachenbruch PA, Seibold J, Zee B, Steen V, Brennan P, Silman AJ, Allegar N, Varga J, Massa M (1993) Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 20:1892\u20131896","journal-title":"J Rheumatol"},{"key":"5126_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.semarthrit.2007.01.005","volume":"37","author":"M Hudson","year":"2007","unstructured":"Hudson M, Steele R, Canadian Scleroderma Research Group, Baron M (2007) Update on indices of disease activity in systemic sclerosis. Semin Arthritis Rheum 37:93\u201398","journal-title":"Semin Arthritis Rheum"},{"key":"5126_CR10","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1136\/ard.62.9.901","volume":"62","author":"G Valentini","year":"2003","unstructured":"Valentini G, Bencivelli W, Bombardieri S, D'Angelo S, Della Rossa A, Silman A (2003) European scleroderma study group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria. Ann Rheum Dis 62:901\u2013903","journal-title":"Ann Rheum Dis"},{"key":"5126_CR11","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s00296-009-1129-7","volume":"30","author":"X Fan","year":"2010","unstructured":"Fan X, Pope J, Canadian Scleroderma Research Group, Baron M (2010) What is the relationship between disease activity, severity and damage in a large Canadian systemic sclerosis cohort? Results from the Canadian Scleroderma Research Group (CSRG). Rheumatol Int 30:1205\u20131210","journal-title":"Rheumatol Int"},{"key":"5126_CR12","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.3899\/jrheum.100354","volume":"37","author":"M Hudson","year":"2010","unstructured":"Hudson M, Impens A, Baron M, Seibold J, Thombs B, Walker J, Canadian Scleroderma Research Group, Steele R (2010) Discordance between patient and physician assessments of disease severity in systemic sclerosis. J Rheumatol 37:2307\u20132312","journal-title":"J Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05126-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-020-05126-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05126-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T23:54:49Z","timestamp":1626825289000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-020-05126-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,21]]},"references-count":12,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5126"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-05126-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,21]]},"assertion":[{"value":"11 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Human research ethics committees at each participating centre approved the study. Written informed consent was obtained from all patients prior to the collection of data.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Associate Professor Mandana Nikpour is the co-chair of the Scleroderma Clinical Trials Consortium (SCTC) Activity Index Working Group.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}